Related Experiment Video
Updated: May 15, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Lipopolysaccharide downregulates CD91/low-density lipoprotein receptor-related protein 1 expression through SREBP-1
P Costales1, J Castellano, E Revuelta-López
1Cardiovascular Research Center, CSIC-ICCC, IIB-Sant Pau, Barcelona, Spain.
Insights
Lipopolysaccharide (LPS) reduces low-density lipoprotein receptor-related protein (LRP1) expression in macrophages by increasing Sterol regulatory element-binding protein-1 (SREBP-1). SREBP-1 mediates this LPS effect, independent of lipoproteins.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Sterol regulatory element-binding proteins (SREBPs) are known to negatively regulate CD91/low-density lipoprotein receptor-related protein (LRP1) expression.
- LRP1 is a crucial receptor involved in endocytosis and signaling, mediating the uptake of numerous ligands.
- Understanding the regulation of LRP1 is vital for comprehending cellular lipid metabolism and immune responses.
Purpose of the Study:
- To investigate whether lipopolysaccharide (LPS) regulates LRP1 expression via SREBPs in human monocyte-derived macrophages (HMDM).
- To elucidate the specific role of SREBP isoforms in mediating the effects of LPS and lipoproteins on LRP1 expression.
Main Methods:
- Human monocyte-derived macrophages (HMDM) were treated with varying doses and durations of LPS.
- Quantitative real-time PCR (qPCR) was used to measure mRNA levels of LRP1 and SREBP isoforms.
- Western blotting was employed to assess protein levels of LRP1 and nuclear SREBP-1.
- Specific silencing of SREBP-1 was performed using gene silencing techniques.
Main Results:
- LPS treatment dose- and time-dependently inhibited LRP1 mRNA and protein expression in HMDM.
- LPS significantly upregulated SREBP-1 mRNA and nuclear protein levels.
- Silencing SREBP-1 prevented the LPS-induced reduction in LRP1 expression.
- Native and aggregated LDL downregulated SREBP-2 and increased LRP1, but did not alter the LPS effect on SREBP-1 and LRP1.
Conclusions:
- SREBP-1 acts as a key mediator for the downregulatory effect of LPS on LRP1 expression in human macrophages.
- Lipoproteins and LPS modulate LRP1 expression through distinct SREBP isoforms (SREBP-2 and SREBP-1, respectively).
- The regulatory effect of LPS on LRP1 is independent of the presence or modification state of LDL.
Abstract:
Sterol regulatory element-binding proteins (SREBPs) negatively modulate the expression of the CD91/low-density lipoprotein receptor-related protein (LRP1), a carrier and signaling receptor that mediates the endocytosis of more than 40 structurally and functionally distinct ligands. The aim of this work was to analyze whether lipopolysaccharide (LPS) can regulate LRP1 expression through SREBPs in human monocyte-derived macrophages (HMDM). LPS led to LRP1 mRNA and protein inhibition in a dose- and time-dependent manner. Concomitantly, a strong upregulation of SREBP-1 mRNA and SREBP-1 nuclear protein levels was observed in LPS-treated HMDM. The specific silencing of SREBP-1 efficiently prevented LRP1 reduction caused by LPS. SREBP-1 mRNA and nuclear protein levels remained high in HMDM treated with LPS unexposed or exposed to LDL. Native (nLDL) or aggregated LDL (agLDL) per se downregulated SREBP-2 expression levels and increased LRP1 expression. However, lipoproteins did not significantly alter the effect of LPS on SREBP-1 and LRP1 expression. Collectively, these data support that lipoproteins and LPS exert their modulatory effect on LRP1 expression through different SREBP isoforms, SREBP-2 and SREBP-1, respectively. These results highlight a crucial role of SREBP-1 as a mediator of the downregulatory effects of LPS on LRP1 expression in human macrophages, independently of the absence or presence of modified lipoproteins.
Related Concept Videos
Inflammation
Regulation of Nuclear Protein Sorting
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Formation of Lipopolysaccharides
